NewsBenzingaBarclays Maintains Overweight on 10x Genomics, Raises Price Target to $110 Barclays Maintains Overweight on 10x Genomics, Raises Price Target to $110 Benzinga 2026.10.07 13:23 (GMT+0) Open on Benzinga Other news 'Saudi Arabia launches air safety probe into flydubai incident, sources say'- Reuters Exclusive Barclays Maintains Overweight on Royal Caribbean Group, Lowers Price Target to $337 Wolfe Research Maintains Outperform on Marvell Technology, Raises Price Target to $375 Watching IREN; Shares Moving Lower; Traders Circulate X Post Saying "IREN continues to come up in our conversations with neocloud customers, and usually for the wrong reasons. In Prince George and Mackenzie in Northern BC, Canada, we’ve heard the... Barclays Maintains Overweight on Robinhood Markets, Raises Price Target to $132 Barclays Maintains Equal-Weight on Revvity, Raises Price Target to $160
Watching IREN; Shares Moving Lower; Traders Circulate X Post Saying "IREN continues to come up in our conversations with neocloud customers, and usually for the wrong reasons. In Prince George and Mackenzie in Northern BC, Canada, we’ve heard the...
